PDF
T/CGCPU 029-2023 Active
T/CGCPU 029-2023 The evaluation requirements for follow-up centers in primary clinical trials
Abstract
Main technical content: Foreword Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions, acronyms 3.1 Terms and definitions 3.2 Acronyms 4 Evaluation content 4.1 Qualifications for conducting clinical trials 4.2 Basic conditions 4.3 Capacity 5 Evaluation process 5.1 Pre-evaluation 5.2 On-site evaluation 5.3 End of on-site evaluation 5.4 After on-site evaluation 6 Evaluation conclusions 6.1 Evaluation clauses 6.2 Conclusion judgment 7 Continuous improvement 7.1 Development of improvement measures Appendix A (Normative) Evaluation content and evaluation grades References
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/CGCPU 029-2023 |
| ICS | Integrated medical science and healthcare devices |
| Implement Date | 2024-01-16 |
Price
$ 20.00
Subtotal
$ 20.00
Tax
$ 0.00
Order Total (incl. tax)
$ 20.00